Clinical Development Of Biosimilars

This track includes Clinical trials on major diseases Risk management, and quality affairs, Case studies, and clinical models, Transgenic animals, Targeted cell line development, Clinical biosimilar tracks.docx PK/PD studies, Toxicological studies and Aspects of genotoxicity tests.Clinical trials are designed in stages I-IV so as to receive a clear picture of the drug candidate in respect to its pharmacokinetics and pharmacodynamics parameters.

Biologics also represent over 40 percent of the drugs in each of the preclinical, Phase I, Phase II, and Phase III trial stages.

  • Biosimilars Clinical Trials
  • Toxicological studies
  • Clinical PK/PD studies
  • Targeted cell line development
  • Transgenic animals
  • Case studies, and clinical models
  • Clinical trials on major diseases
  • Biosimilars Clinical Studies
  • Aspects of genotoxicity tests
  • Case studies and clinical models
  • Biologics Product Life Cycle and Sustainable Market Returns

Related Conference of Clinical Development Of Biosimilars

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Clinical Development Of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in